Your activity: 6 p.v.

US multi-society task force recommendations for post-colonoscopy follow-up in average-risk adults with normal colonoscopy or adenomas*

US multi-society task force recommendations for post-colonoscopy follow-up in average-risk adults with normal colonoscopy or adenomas*
Baseline colonoscopy finding Recommended interval for surveillance colonoscopy Strength of recommendation Quality of evidence
Normal 10 years Strong High
1 to 2 tubular adenomas <10 mm 7 to 10 yearsΔ Strong Moderate
3 to 4 tubular adenomas <10 mm 3 to 5 years Weak Very low
5 to 10 tubular adenomas <10 mm 3 years Strong Moderate
Adenoma ≥10 mm 3 years Strong High
Adenoma with tubulovillous or villous histology 3 years Strong Moderate
Adenoma with high-grade dysplasia 3 years Strong Moderate
>10 adenomas on single examination§ 1 year Weak Very low
Piecemeal resection of adenoma ≥20 mm 6 months Strong Moderate¥
CRC: colorectal cancer.
* All recommendations assume examination complete to cecum with bowel preparation adequate to detect lesions >5 mm in size; recommendations do not apply to individuals with a hereditary CRC syndrome, personal history of inflammatory bowel disease, personal history of hereditary cancer syndrome, serrated polyposis syndrome, malignant polyp, personal history of CRC, or family history of CRC, and must be judiciously applied to such individuals, favoring the shortest indicated interval based on either history or polyp findings.
¶ Follow-up may be with colonoscopy or other screening modality for average-risk individuals.
Δ Patients with recommendations issued before 2020 for shorter than 7- to 10-year follow-up after diagnosis of 1 to 2 tubular adenomas may follow original recommendations. If feasible, physicians may re-evaluate patients previously recommended an interval shorter than 10 years and reasonably choose to provide an updated recommendation for 7- to 10-year follow-up, taking into account factors such as quality of baseline examination, polyp history, and patient preferences.
Assumes high confidence of complete resection.
§ Patients with >10 adenomas or lifetime >10 cumulative adenomas may need to be considered for genetic testing based on absolute/cumulative adenoma number, patient age, and other factors such as family history of CRC (refer to UpToDate text).
¥ Refer to US Multi-Society Task Force recommendations for endoscopic removal of colorectal lesions.
From: Gupta S, Lieberman D, Anderson JC, et al. Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2020. DOI: 10.14309/ajg.0000000000000544. Copyright © 2020 the American College of Gastroenterology, the AGA Institute, and the American Society for Gastrointestinal Endoscopy. Reproduced with permission from Wolters Kluwer Health. Unauthorized reproduction of this material is prohibited.
Graphic 127123 Version 3.0